EC Microbiology

Review Article Volume 21 Issue 12 - 2025

Eosinophilic Gastrointestinal Diseases and their Impact on the Intestinal Microbiome

Álvaro Zamudio Tiburcio1*, Héctor Bermúdez Ruiz2, Silverio Alonso López3 and Pedro Antonio Reyes López4

1Department of Gastroenterology, Intestinal Microbiota Transplantation, Medical Specialties, Naples Unit, Mexico

2Endoscopy Service, Oncology Hospital, National Medical Center, XXI Century, Mexican Social Security Institute, Mexico

3Department of Urologist, Chairman Medical Specialties Naples in Mexico City, Mexico

4Immunologist, Rheumatologist, National Institute of Cardiology “I. Chávez”, Mexico City, Mexico

*Corresponding Author: Álvaro Zamudio Tiburcio, Department of Gastroenterology, Intestinal Microbiota Transplantation, Medical Specialties, Naples Unit, Mexico.
Received: November 14, 2025; Published: November 27, 2025



In the last decade, articles have been published regarding the increased incidence of primary eosinophilic digestive diseases linked to atopy. This has led to efforts to minimize their negative impact, due to repeated diagnostic errors caused by their rarity and the tendency to focus on other, more common pathologies. To highlight this pathology, we explore what occurs from the esophagus to the colon when affected by eosinophilic disorders.

 Keywords: Eosinophilic Esophagitis (EE); Eosinophilic Gastroenteritis (EGE); Eosinophilic Colitis (EC); Gut Microbiome (GM)

  1. Eechsler ME., et al. “Eosinophils in health and disease: a state-of-the-art review”. Mayo Clinic Proceedings10 (2021): 2694-2707.
  2. Thel HL., et al. “Prevalence and costs of eosinophilic esophagitis in the United States”. Clinical Gastroenterology and Hepatology 2 (2025): 272-280.e8.
  3. Walker MM., et al. “Eosinophilic gastroenteritis and other eosinophilic gut diseases distal to the oesophagus”. Lancet Gastroenterology and Hepatology 4 (2018): 271-280.
  4. Kinoshita Y., et al. “Eosinophilic gastrointestinal diseases: The pathogenesis, diagnosis, and treatment”. Internal Medicine 1 (2023): 1-10.
  5. Gurtner A., et al. “Intestinal eosinophils, homeostasis and response to bacterial intrusion”. Seminars in Immunopathology 3 (2021): 295-306.
  6. Qian G., et al. “Exploring the etiology of colitis: insights from gut microbiota research”. Gut Microbes1 (2025): 2512010.
  7. Zhang X., et al. “Eosinophilic esophagitis and esophageal microbiota”. Frontiers in Cellular and Infection Microbiology 13 (2023): 1206343.
  8. Rabassa-Pérez R., et al. Archivo Médico Camagüey 26 (2022): e8843.
  9. Dellon ES., et al. “Determination of biopsy yield that optimally detects eosinophilic gastritis and/or duodenitis in a randomized trial of lirentelimab”. Clinical Gastroenterology and Hepatology3 (2022): 535-545.e15.
  10. Tetsuo Shoda., et al. “Molecular analysis of duodenal eosinophilia”. Journal of Allergy and Clinical Immunology4 (2023): 1027-1039.
  11. Kinoshita Y and Ishihara S. “Eosinophilic gastroenteritis: epidemiology, diagnosis, and treatment”. Current Opinion in Allergy and Clinical Immunology 3 (2020): 311-315.
  12. Qian G., et al. “Exploring the etiology of colitis: insights from gut microbiota research”. Gut Microbes1 (2025): 2512010.
  13. Soni M., et al. “Eosinophilic gastrointestinal disease”. Journal of the American Medical Association 16 (2024): 1407-1408.
  14. Kinoshita Y., et al. “Eosinophilic gastrointestinal diseases: The pathogenesis, diagnosis, and treatment”. Internal Medicine 1 (2023): 1-10.
  15. Yalon M., et al. “Eosinophilic disorders of the gastrointestinal tract and associated abdominal viscera: imaging findings and diagnosis”. RadioGraphic4 (2022): 1081-1102.
  16. Zalewski A., et al. “Long-term outcomes of the six-food elimination diet and food reintroduction in a large cohort of adults with eosinophilic esophagitis”. The American Journal of Gastroenterology 12 (2022): 1963-1970.
  17. Molina-Infante J and Lucendo AJ. “Update on topical steroid therapy for eosinophilic esophagitis”. Gastroenterology and Hepatology 6 (2015): 388-397.
  18. Dai YX., et al. “Fecal microbiota transplantation and prednisone for severe eosinophilic gastroenteritis”. World Journal of Gastroenterology 43 (2014): 16368-16371.
  19. Jasiński M., et al. “Eosinophilic gastroenteritis and graft-versus-host disease induced by transmission of norovirus with fecal microbiota transplant-2”. Journal of Inflammatory Bowel Diseases and Disorders3 (2021): e13386.
  20. Núñez PF., et al. “Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases”. Gastroenterology and Hepatology 3 (2022): 223-230.
  21. Hou S., et al. “Advances in fecal microbiota transplantation for gut dysbiosis-related diseases”. Advances Science13 (2025): e2413197.
  22. Nguyen MT., et al. “Eosinophilic gastrointestinal disorders (EGIDs) treatment and management”. Medscape (2025).
  23. Fan Y., et al. “Long-read metagenomics for strain tracking after faecal microbiota transplant”. Nature Microbiology (2025).
  24. Sunkara T., et al. “Eosinophilic gastroenteritis: diagnosis and clinical perspectives”. Clinical and Experimental Gastroenterology 12 (2019): 239-253.
  25. Shah A., et al. “Duodenal eosinophils and mast cells in functional dyspepsia: a systematic review and meta-analysis of case-control studies”. Clinical Gastroenterology and Hepatology10 (2022): 2229-2242.e29.
  26. Dikerson A., et al. “Future of therapy and monitoring for eosinophilic esophagitis and eosinophilic gastrointestinal diseases”. Annals of Allergy, Asthma and Immunology2 (2025): 143-154.

Álvaro Zamudio Tiburcio., et al. “Eosinophilic Gastrointestinal Diseases and their Impact on the Intestinal Microbiome”. EC Microbiology  21.12 (2025): 01-06.

ECronicon Journal

Our Services

Quick Links

Information

Creative Commons LicenseOpen Access by ECronicon is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at www.ecronicon.net